05-Mar-2015 - Higher capacity utilization is improving prices across the non-clinical research sector according to Huntingdon Life Sciences CEO Brian Cass, who told Outsourcing-pharma.com the preclinical CRO may add scale to US...
05-Mar-2015 - For the second straight year Charles River Laboratories has seen more of its revenue derived from biotech companies than Big Pharma, CEO James Foster told investors at two conferences on...
24-Feb-2015 - Huntingdon Life Sciences has announced it will change its name this year, but has not disclosed what its new moniker will be. So Outsourcing-pharma.com would welcome readers’ suggestions.
17-Feb-2015 - Preclinical CRO Crown is acquiring all of Molecular Response’s existing PDX (patient-derived xenograft) models as well as 8,000 viable human tumors for model development.
16-Feb-2015 - Charles River Laboratories is nearing the acquisition of an early-stage drug discovery company, CEO James Foster told attendees at the Leerink Swann Global Healthcare Conference last week.
11-Feb-2015 - CRO Charles River Laboratories is further exploring the idea of re-opening a preclinical site in Shrewsbury, MA, though it will be more than a year before the site is ready.
02-Feb-2015 - Contract research organization (CRO) Horizon has been selected as a “core facility” for supplying biopharma research tools to academic group the Tri-Institutional Therapeutics Discovery Institute.
29-Jan-2015 - AstraZeneca has partnered to use the CRISPR genome editing technique across its discovery programmes in a move that puts it on a collision course with French Biotech, Cellectis.
23-Jan-2015 - Investment firm William Blair has upgraded preclinical CRO Charles River Laboratories to ‘outperform’ based on strong toxicology demand and the pending acquisition of Covance.
21-Jan-2015 - Covance is looking to speed early drug development by setting up teams of experts to help sponsors bridge their preclinical and clinical development.
15-Jan-2015 - CRO Charles River Laboratories (CRL) may re-open a preclinical site in Shrewsbury, MA, if demand for the site perks up in the near future.
12-Jan-2015 - Crown Biosciences has announced plans to double capacity at a site operated by its Precos division.
12-Jan-2015 - Ansun Biopharma will pay out over $2m (€1.6m) after committing fraud against the National Institutes of Health (NIH) to siphon money for cash flow problems.
12-Jan-2015 - PPD’s recently acquired biotech company X-Chem is launching a multi-target collaboration with Janssen Biotech. Financial terms of the deal were not disclosed.
09-Jan-2015 - Horizon says its £6m (€7.7m) purchase of Austrian biotech Haplogen Genomics means it can produce cell lines ten times faster than before using a haploid gene platform.
23-Dec-2014 - On two separate incidents in September and October, a total of 13 primates died at a Covance research facility in Alice, Texas due to hyperthermia.
19-Dec-2014 - PPD’s biotech company X-Chem has licensed a second drug discovery program to Bayer Pharma, which follows on a multi-target collaboration the companies established in 2012.
18-Dec-2014 - Regulatory reviewers spend more time managing incoming data than on the drug evaluation process, says Instem which has inked a deal with WIL Research for its nonclinical IT systems.
09-Dec-2014 - Horizon Discovery Group announced Monday that its bioproduction division has shipped its first commercially available engineered CHO (Chinese Hamster Ovary) cell line for use in manufacturing of antibodies.
08-Dec-2014 - Over the last three years US turnover in clinical monitoring has dropped from 29.4% to 16.4% and globally overall company turnover has dropped from 27.2% to 14.2% on average, according...
03-Dec-2014 - Evotec and Sanofi have entered into exclusive negotiations for a major strategic partnership that will include a €250m ($310m) minimum guaranteed commitment from Sanofi over the next five years.
20-Nov-2014 - A preclinical biotech backed by Bristol-Myers Squibb is forming a strategic alliance with Synergy Partners R&D Solutions to boost academic discoveries.
18-Nov-2014 - Sponsors are turning to outsourcing earlier for help with bioavailability formulation, say contract research organisations (CROs)
18-Nov-2014 - Ricerca Biosciences has been bought by private equity group Main Market Partners in a deal that means the contract research organisation's (CRO) 199 employees keep their jobs.
10-Nov-2014 - Indian CRO GVK BIO announced the signing of a definitive agreement to acquire Vanta Bioscience, a full service preclinical GLP toxicology and safety assessment CRO operating out of Chennai, India.